Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Isorhamnetin.
Isorhamnetin is a 3'-O-methylated flavonoid that exhibits potent antioxidant, anti-inflammatory, and cardiovascular protective effects by modulating the PI3K/Akt and NF-κB signaling pathways.
5281654
316.26 g/mol
1.9
3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Isorhamnetin across standard consumer modalities.
Low aqueous solubility and high first-pass metabolism necessitate the use of lipid-based carriers or micronization to ensure adequate bioavailability in dry powder formats.
The phenolic structure may undergo oxidative degradation or cause astringent off-notes if the pH of the pectin matrix is not strictly controlled.
Payload capacity is severely limited by the molecule's low potency-to-weight ratio and the requirement for solubilizers to prevent recrystallization within the polymer matrix.
Ready to launch a product featuring Isorhamnetin? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Isorhamnetin extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Isorhamnetin payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation